⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfamide SCHEMBL9647921 | 0.84 | — | — | |
| Butane SCHEMBL569939 | 0.84 | — | — | |
| Sulfamide SCHEMBL10457261 | 0.84 | CA1 (0.55) | — | |
| Butane SCHEMBL27385503 | 0.80 | CA1 (0.35) | — | |
| Methanesulfonamide SCHEMBL10465450 | 0.80 | — | — | |
| SCHEMBL147667 | 0.78 | — | — | |
| Butane SCHEMBL10628052 | 0.77 | — | — | |
| Ethanesulfonic Acid Amide SCHEMBL6507946 | 0.74 | CA2 (0.38) | — | |
| Propylamine SCHEMBL27857651 | 0.74 | — | — | |
| Ethanesulfonic Acid Amide SCHEMBL6507948 | 0.74 | CA2 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4363400-A1 | SYNTHESIS OF N,N-DIALKYL, -DIALKENYL, -DIALKYNYL, AND RELATED CYCLICS, SULFAMOYL FLUORIDE COMPOUNDS USING HYDROGEN FLUORIDE | SES Holdings Pte. Ltd. (SG) | 2024-05-08 | — | — | EP | disclosed |
| CN-117956992-A | MENIN-MLL interaction inhibitors | 赛达克斯制药股份有限公司 | 2024-04-30 | — | — | CN | disclosed |
| WO-2023275607-A1 | SYNTHESIS OF N,N-DIALKYL, -DIALKENYL, -DIALKYNL, AND RELATED CYCLICS, SULFAMOYL FLUORIDE COMPOUNDS USING HYDROGEN FLUORIDE | SES HOLDINGS PTE. LTD. (SG) | 2023-01-05 | — | — | WO | disclosed |
| US-20220251085-A1 | CYSTEINE BINDING COMPOSITIONS AND METHODS OF USE THEREOF | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2022-08-11 | — | — | US | disclosed |
| US-20080045524-A1 | Selective NPY (Y5) antagonists | H. LUNDBECK A/S (DK) | 2008-02-21 | — | — | US | disclosed |
| EP-1778654-A1 | SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME | Crystalgenomics, Inc. (KR) | 2007-05-02 | — | — | EP | disclosed |
| US-7189720-B2 | Selective NPY (Y5) antagonists | H. LUNDBECK A/S (DK) | 2007-03-13 | — | — | US | disclosed |
| US-6989379-B1 | Selective NPY (Y5) antagonists | H. LUNDBICK A/S (DK) | 2006-01-24 | — | — | US | disclosed |
| WO-2006006832-A1 | SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME | CRYSTALGENOMICS, INC. (KR) | 2006-01-19 | — | — | WO | disclosed |
| US-20050176709-A1 | Selective NPY (Y5) antagonists | H. LUNDBECK A/S (DK) | 2005-08-11 | — | — | US | disclosed |
| US-6218408-B1 | FOR THERAPY OF EATING DISORDERS | SYNAPTIC PHARMACEUTICAL CORPORATION | 2001-04-17 | — | — | US | disclosed |